Obesity drugs show promise in combatting substance abuse

GLP-1 receptor agonists, initially for diabetes and weight loss, show promise in substance addiction treatment. A transformative breakthrough in healthcare.

This article is for Health Matters subscribers

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in

More from Health Matters

10.10.2026

JSE healthcare shares gain as Aspen cuts debt and hospitals improve margins. Explore the growth drivers and risks facing the sector.

08.10.2026

Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.

08.10.2026

Hospitals are investing in infection prevention and control as antimicrobial resistance rises, but experts say gaps remain.